Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1<sup>+</sup> patients

<p>Abstract</p> <p>Background</p> <p>The immune system reconstitution in HIV-1- infected patients undergoing combined antiretroviral therapy is routinely evaluated by T-cell phenotyping, even though the infection also impairs the B-cell mediated immunity. To find new la...

Full description

Bibliographic Details
Main Authors: Quiros-Roldan Eugenia, Serana Federico, Chiarini Marco, Zanotti Cinzia, Sottini Alessandra, Gotti Daria, Torti Carlo, Caimi Luigi, Imberti Luisa
Format: Article
Language:English
Published: BMC 2012-05-01
Series:Journal of Translational Medicine
Subjects:
Online Access:http://www.translational-medicine.com/content/10/1/94
_version_ 1828258912107757568
author Quiros-Roldan Eugenia
Serana Federico
Chiarini Marco
Zanotti Cinzia
Sottini Alessandra
Gotti Daria
Torti Carlo
Caimi Luigi
Imberti Luisa
author_facet Quiros-Roldan Eugenia
Serana Federico
Chiarini Marco
Zanotti Cinzia
Sottini Alessandra
Gotti Daria
Torti Carlo
Caimi Luigi
Imberti Luisa
author_sort Quiros-Roldan Eugenia
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The immune system reconstitution in HIV-1- infected patients undergoing combined antiretroviral therapy is routinely evaluated by T-cell phenotyping, even though the infection also impairs the B-cell mediated immunity. To find new laboratory markers of therapy effectiveness, both B- and T- immune recovery were evaluated by means of a follow-up study of long-term treated HIV-1- infected patients, with a special focus on the measure of new B- and T-lymphocyte production.</p> <p>Methods</p> <p>A longitudinal analysis was performed in samples obtained from HIV-1-infected patients before therapy beginning and after 6, 12, and 72 months with a duplex real-time PCR allowing the detection of K-deleting recombination excision circles (KRECs) and T-cell receptor excision circles (TRECs), as measures of bone-marrow and thymic output, respectively. A cross sectional analysis was performed to detect B- and T-cell subsets by flow cytometry in samples obtained at the end of the follow-up, which were compared to those of untreated HIV-1-infected patients and uninfected controls.</p> <p>Results</p> <p>The kinetics and the timings of B- and T-cell release from the bone marrow and thymus during antiretroviral therapy were substantially different, with a decreased B-cell release and an increased thymic output after the prolonged therapy. The multivariable regression analysis showed that a longer pre-therapy infection duration predicts a minor TREC increase and a major KREC reduction.</p> <p>Conclusions</p> <p>The quantification of KRECs and TRECs represents an improved method to monitor the effects of therapies capable of influencing the immune cell pool composition in HIV-1-infected patients.</p>
first_indexed 2024-04-13T02:59:46Z
format Article
id doaj.art-67cb46619217449088809d4116ae51f0
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-13T02:59:46Z
publishDate 2012-05-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-67cb46619217449088809d4116ae51f02022-12-22T03:05:28ZengBMCJournal of Translational Medicine1479-58762012-05-011019410.1186/1479-5876-10-94Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1<sup>+</sup> patientsQuiros-Roldan EugeniaSerana FedericoChiarini MarcoZanotti CinziaSottini AlessandraGotti DariaTorti CarloCaimi LuigiImberti Luisa<p>Abstract</p> <p>Background</p> <p>The immune system reconstitution in HIV-1- infected patients undergoing combined antiretroviral therapy is routinely evaluated by T-cell phenotyping, even though the infection also impairs the B-cell mediated immunity. To find new laboratory markers of therapy effectiveness, both B- and T- immune recovery were evaluated by means of a follow-up study of long-term treated HIV-1- infected patients, with a special focus on the measure of new B- and T-lymphocyte production.</p> <p>Methods</p> <p>A longitudinal analysis was performed in samples obtained from HIV-1-infected patients before therapy beginning and after 6, 12, and 72 months with a duplex real-time PCR allowing the detection of K-deleting recombination excision circles (KRECs) and T-cell receptor excision circles (TRECs), as measures of bone-marrow and thymic output, respectively. A cross sectional analysis was performed to detect B- and T-cell subsets by flow cytometry in samples obtained at the end of the follow-up, which were compared to those of untreated HIV-1-infected patients and uninfected controls.</p> <p>Results</p> <p>The kinetics and the timings of B- and T-cell release from the bone marrow and thymus during antiretroviral therapy were substantially different, with a decreased B-cell release and an increased thymic output after the prolonged therapy. The multivariable regression analysis showed that a longer pre-therapy infection duration predicts a minor TREC increase and a major KREC reduction.</p> <p>Conclusions</p> <p>The quantification of KRECs and TRECs represents an improved method to monitor the effects of therapies capable of influencing the immune cell pool composition in HIV-1-infected patients.</p>http://www.translational-medicine.com/content/10/1/94KRECsTRECsHIV-1cARTT lymphocytesB lymphocytes
spellingShingle Quiros-Roldan Eugenia
Serana Federico
Chiarini Marco
Zanotti Cinzia
Sottini Alessandra
Gotti Daria
Torti Carlo
Caimi Luigi
Imberti Luisa
Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1<sup>+</sup> patients
Journal of Translational Medicine
KRECs
TRECs
HIV-1
cART
T lymphocytes
B lymphocytes
title Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1<sup>+</sup> patients
title_full Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1<sup>+</sup> patients
title_fullStr Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1<sup>+</sup> patients
title_full_unstemmed Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1<sup>+</sup> patients
title_short Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1<sup>+</sup> patients
title_sort effects of combined antiretroviral therapy on b and t cell release from production sites in long term treated hiv 1 sup sup patients
topic KRECs
TRECs
HIV-1
cART
T lymphocytes
B lymphocytes
url http://www.translational-medicine.com/content/10/1/94
work_keys_str_mv AT quirosroldaneugenia effectsofcombinedantiretroviraltherapyonbandtcellreleasefromproductionsitesinlongtermtreatedhiv1supsuppatients
AT seranafederico effectsofcombinedantiretroviraltherapyonbandtcellreleasefromproductionsitesinlongtermtreatedhiv1supsuppatients
AT chiarinimarco effectsofcombinedantiretroviraltherapyonbandtcellreleasefromproductionsitesinlongtermtreatedhiv1supsuppatients
AT zanotticinzia effectsofcombinedantiretroviraltherapyonbandtcellreleasefromproductionsitesinlongtermtreatedhiv1supsuppatients
AT sottinialessandra effectsofcombinedantiretroviraltherapyonbandtcellreleasefromproductionsitesinlongtermtreatedhiv1supsuppatients
AT gottidaria effectsofcombinedantiretroviraltherapyonbandtcellreleasefromproductionsitesinlongtermtreatedhiv1supsuppatients
AT torticarlo effectsofcombinedantiretroviraltherapyonbandtcellreleasefromproductionsitesinlongtermtreatedhiv1supsuppatients
AT caimiluigi effectsofcombinedantiretroviraltherapyonbandtcellreleasefromproductionsitesinlongtermtreatedhiv1supsuppatients
AT imbertiluisa effectsofcombinedantiretroviraltherapyonbandtcellreleasefromproductionsitesinlongtermtreatedhiv1supsuppatients